Volume: 5 Issue: 2
Year: 2017, Page: 8-12,
Objectives: To study the role of fluorescein angiography in the evaluation of posterior segment diseases.
Materials & Methods :A hospital based prospective randomized study was done which included 80 patients. Detailed patient history was taken and a thorough ocular and systemic examination was done. All patients were examined by ophthalmoscopy (direct, indirect and slit lamp examination with +90 D lens), followed by fluorescein angiography. Ophthalmoscopic and fluorescein angiography findings were analyzed and categorized. Patients were advised necessary ocular and systemic treatment.
Results : 80 cases with posterior segment diseases were analyzed and sub-divided into categories of Diabetic retinopathy, vascular occlusive disorders, age related macular degenerations, Central serous chorioretinopathy, inflammatory disorders and miscellaneous conditions. Fundus Fluorescein Angiography (FFA) altered the diagnosis in 37.5% of cases and categorized the lesions in all cases. 11% of patients experienced adverse reactions like nausea and vomiting. On statistical analysis, FFA proved to be a far superior diagnostic modality than clinical examination (ophthalmoscopy) in diagnosing fundus pathology.
Conclusion :FFA is a superior diagnostic tool and is a necessity for evaluating, localizing and categorization of lesions in Retinal, Macular and Choroidal pathologies.
Keywords: Fundus Fluorescein Angiography, Diabetic retinopathy, Age related macular degenerations, Central serous chorioretinopathy.
1. Kanski JJ. Retinal vascular diseases. Chapter 16, In : Clinical ophthalmology – A systemic approach, 6th edn. New Delhi; Elsevier 2007:p.567.
2. Yanoff M, Duker J. Fluorescein and ICG angiography. In: Clinical ophthalmology, 2nd edn. Hosby 2004:p.300-301.
3. Chao P, Flocks M. The retinal circulation time. Am JOphthalmol 1958;46(Pt.2):8.2011 p.601.
4. Novotny HR, Alvis DL. A method of photographing fluorescence in circulating blood in the human retina. Circulation 1961;24:82
5. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. et al. The Wisconsinepidemiologic study of diabetic retinopathy II (WESDR ).Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520.
6. Kahn HA, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol 1974;78:58.
7. Wykes WN, Livesey SJ. Review of fluorescein angiograms performed in one year. Br J Ophthalmol 1991July; 75(7):398-400.
8. Hayrch SS. Retinal vein occlusion. Indian J Ophthalmol 1994; 42:109.
9. Talks J, Koshy Z, Chatzinikolas K. Use of optical coherence tomography, fluorescein angiography and indocyanine green angiography in a screening clinic for wet age-related macular degeneration. Br J Ophthalmol. 2007 May; 91(5):600–601.
10. Suresha AR, Deepthi molletti et al. Role of fundus fluroscein angiography in macular disorders. IJBR (2014); 05 :( 10)
11. Siddiqui SJ, Ali Shah SI, Pechuho MA, Abbasi SA, Shaikh FF. Pattern of central serous chorioretinopathy (CSCR) of fundus flourescein angiography. Pak Journal Ophthalmol 2008; 24(4):171-175.
12. Kwan AS, Barry C, McAllister IL, Constable I. Fluorescein angiography and adverse drug reactions revisited: Lions eye experience.76 Clin Experiment Ophthalmol 2006 JanFeb;34(1):33-8.
Arvind R ,Surendar S, Jagan Mohan Rao. Role of Fluorescein angiography in evaluation of posterior segment disorders. Perspectives in Medical Research 2017;5(2):8-12.